Sort   by:  
 Page size 
UnknownRituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
Not available
S-EPMC5569679 | biostudies-literature
UnknownEarly experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.
Not available
S-EPMC7329607 | biostudies-literature
UnknownThe time is ripe for the renaissance of autism treatments: evidence from clinical practitioners.
Not available
S-EPMC10437220 | biostudies-literature
UnknownIncreased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.
Not available
S-EPMC6261782 | biostudies-literature
UnknownLow grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy.
Not available
S-EPMC10018679 | biostudies-literature
UnknownSolitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report.
Not available
S-EPMC5711767 | biostudies-literature
UnknownLow-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape.
Not available
S-EPMC6225039 | biostudies-literature
UnknownTrends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019.
Not available
S-EPMC9250056 | biostudies-literature
UnknownAUG sequences are required to sustain nonsense-codon-mediated suppression of splicing.
Not available
S-EPMC1524910 | biostudies-literature
UnknownVery low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Not available
S-EPMC10962616 | biostudies-literature
Sort   by:  
 Page size